343 related articles for article (PubMed ID: 30684452)
1. Heart Failure With Preserved Ejection Fraction: Is Ischemia Due to Coronary Microvascular Dysfunction a Mechanistic Factor?
Elgendy IY; Pepine CJ
Am J Med; 2019 Jun; 132(6):692-697. PubMed ID: 30684452
[TBL] [Abstract][Full Text] [Related]
2. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
3. Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.
Dryer K; Gajjar M; Narang N; Lee M; Paul J; Shah AP; Nathan S; Butler J; Davidson CJ; Fearon WF; Shah SJ; Blair JEA
Am J Physiol Heart Circ Physiol; 2018 May; 314(5):H1033-H1042. PubMed ID: 29424571
[TBL] [Abstract][Full Text] [Related]
4. Heart failure with preserved ejection fraction in hypertension.
Teo LY; Chan LL; Lam CS
Curr Opin Cardiol; 2016 Jul; 31(4):410-6. PubMed ID: 27070649
[TBL] [Abstract][Full Text] [Related]
5. Reduced Myocardial Flow in Heart Failure Patients With Preserved Ejection Fraction.
Srivaratharajah K; Coutinho T; deKemp R; Liu P; Haddad H; Stadnick E; Davies RA; Chih S; Dwivedi G; Guo A; Wells GA; Bernick J; Beanlands R; Mielniczuk LM
Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27413034
[TBL] [Abstract][Full Text] [Related]
6. Frequency of Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis (Measured by Cardiovascular Magnetic Resonance) in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
Löffler AI; Pan JA; Balfour PC; Shaw PW; Yang Y; Nasir M; Auger DA; Epstein FH; Kramer CM; Gan LM; Salerno M
Am J Cardiol; 2019 Nov; 124(10):1584-1589. PubMed ID: 31575425
[TBL] [Abstract][Full Text] [Related]
7. The Role of Systemic Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction.
Weerts J; Mourmans SGJ; Barandiarán Aizpurua A; Schroen BLM; Knackstedt C; Eringa E; Houben AJHM; van Empel VPM
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204779
[TBL] [Abstract][Full Text] [Related]
8. Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction.
Sinha A; Rahman H; Webb A; Shah AM; Perera D
Eur Heart J; 2021 Nov; 42(43):4431-4441. PubMed ID: 34529791
[TBL] [Abstract][Full Text] [Related]
9. Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction.
Tona F; Montisci R; Iop L; Civieri G
Rev Cardiovasc Med; 2021 Mar; 22(1):97-104. PubMed ID: 33792251
[TBL] [Abstract][Full Text] [Related]
10. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
[TBL] [Abstract][Full Text] [Related]
11. Progression of coronary microvascular dysfunction to heart failure with preserved ejection fraction: a case report.
Joung S; Wei J; Nelson MD; Aldiwani H; Shufelt C; Tamarappoo B; Berman D; Thomson LEJ; Bairey Merz CN
J Med Case Rep; 2019 May; 13(1):134. PubMed ID: 31056078
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in proteomic correlates of coronary microvascular dysfunction among patients with heart failure and preserved ejection fraction.
Chandramouli C; Ting TW; Tromp J; Agarwal A; Svedlund S; Saraste A; Hage C; Tan RS; Beussink-Nelson L; Lagerström Fermer M; Gan LM; Lund L; Shah SJ; Lam CSP
Eur J Heart Fail; 2022 Apr; 24(4):681-684. PubMed ID: 35060248
[TBL] [Abstract][Full Text] [Related]
13. Microvascular dysfunction in patients with heart failure with preserved ejection fraction: A meta-analysis.
Azuma M; Kato S; Fukui K; Horita N; Utsunomiya D
Microcirculation; 2023 Oct; 30(7):e12822. PubMed ID: 37491798
[TBL] [Abstract][Full Text] [Related]
14. Coronary Microcirculation in Heart Failure with Preserved Systolic Function.
Vasiljevic Z; Krljanac G; Zdravkovic M; Lasica R; Trifunovic D; Asanin M
Curr Pharm Des; 2018; 24(25):2960-2966. PubMed ID: 29992878
[TBL] [Abstract][Full Text] [Related]
15. Current Perspectives on Systemic Hypertension in Heart Failure with Preserved Ejection Fraction.
Tam MC; Lee R; Cascino TM; Konerman MC; Hummel SL
Curr Hypertens Rep; 2017 Feb; 19(2):12. PubMed ID: 28233237
[TBL] [Abstract][Full Text] [Related]
16. Heart failure with preserved ejection fraction (HFpEF) pathophysiology study (IDENTIFY-HF): does increased arterial stiffness associate with HFpEF, in addition to ageing and vascular effects of comorbidities? Rationale and design.
Ali D; Callan N; Ennis S; Powell R; McGuire S; McGregor G; Weickert MO; Miller MA; Cappuccio FP; Banerjee P
BMJ Open; 2019 Nov; 9(11):e027984. PubMed ID: 31748285
[TBL] [Abstract][Full Text] [Related]
17. Coronary microvascular dysfunction and heart failure with preserved ejection fraction: what are the mechanistic links?
Sinha A; Rahman H; Perera D
Curr Opin Cardiol; 2023 Nov; 38(6):521-526. PubMed ID: 37668191
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Metabolic-Inflammatory Circuit in Heart Failure With Preserved Ejection Fraction.
Yap EP; Kp MMJ; Ramachandra CJ
Curr Heart Fail Rep; 2022 Jun; 19(3):63-74. PubMed ID: 35403986
[TBL] [Abstract][Full Text] [Related]
19. Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection Fraction.
Paulus WJ; Dal Canto E
JACC Heart Fail; 2018 Jan; 6(1):1-7. PubMed ID: 29284577
[TBL] [Abstract][Full Text] [Related]
20. Implications of coronary artery disease in heart failure with preserved ejection fraction.
Hwang SJ; Melenovsky V; Borlaug BA
J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2817-27. PubMed ID: 24768876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
